Trials / Completed
CompletedNCT02343978
Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)
Phase II, Randomized, Open-label Study of KWA-0711 Administrated Orally for 2 Weeks to Evaluate Its Safety and Efficacy in Patients With Chronic Constipation (CC)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the safety and efficacy of KWA-0711 in Chronic Constipation (CC) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KWA-0711 |
Timeline
- Start date
- 2014-12-26
- Primary completion
- 2015-05-01
- First posted
- 2015-01-22
- Last updated
- 2017-05-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02343978. Inclusion in this directory is not an endorsement.